Riskpilot← Back to searchSign inGet full accessHEMO AS
ASActiveOrg 997823052Eidsvegen 11, 5211 OsManufacture of wooden containers · NACE 1624Est. 20125 employees
Revenue 2025
NOK 6,2M
+62% vs 2024
EBITDA margin
40.0%
+463% vs 2024
Equity ratio
55.5%
Financial strength
Net profit 2025
NOK 1,9M
+479% vs 2024
| Revenue | NOK 6,2M | +62% |
| EBITDA | NOK 2,5M | +463% |
| Net profit | NOK 1,9M | +479% |
| Total assets | NOK 2,6M | +91% |
| Equity | NOK 1,5M | +170% |
| Employees | 5 | — |
Legal name
HEMO AS
Org number
997823052
Legal form
Aksjeselskap
NACE code
1624 · Manufacture of wooden containers
Founded
12. januar 2012
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Snekkerverksted med produksjon av produkter i tre. Selskapet kan delta i andre virksomehter.
Address
Eidsvegen 11, 5211 Os
Phone
+4756309840
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 285 | 2 721 | 4 327 | 4 132 | 2 910 | 2 287 | 3 150 | 3 848 | 2 902 | 3 265 | 2 494 | 1 680 | 3 823 | 6 188 |
| Staff expenses | −852 | −1 047 | −1 340 | −1 451 | −1 364 | −1 149 | −1 249 | −1 555 | −1 629 | −1 293 | −1 009 | −739 | −2 129 | −1 569 |
| EBITDA | 874 | 848 | 1 801 | 1 497 | 603 | 333 | 819 | 1 170 | 260 | 542 | −146 | 49 | 440 | 2 476 |
| Depreciation & amort. | −0 | −0 | −11 | −18 | −20 | −20 | −17 | −15 | −17 | −25 | −25 | −25 | −14 | −8 |
| EBIT | 874 | 848 | 1 790 | 1 479 | 583 | 313 | 802 | 1 155 | 243 | 517 | −171 | 24 | 426 | 2 467 |
| Net financials | −8 | 3 | 5 | 3 | 1 | 0 | 0 | 2 | 2 | 0 | −0 | −1 | 0 | −0 |
| Profit before tax | 865 | 851 | 1 796 | 1 482 | 584 | 313 | 802 | 1 157 | 245 | 517 | −171 | 23 | 426 | 2 467 |
| Tax | 240 | 238 | 485 | 398 | 146 | 75 | 184 | 255 | 54 | 114 | −38 | 5 | 94 | 543 |
| Net profit | 625 | 613 | 1 311 | 1 084 | 439 | 238 | 618 | 903 | 191 | 403 | −133 | 18 | 332 | 1 924 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 082 | 1 405 | 2 206 | 2 087 | 1 080 | 1 049 | 1 327 | 1 715 | 1 114 | 1 121 | 707 | 746 | 1 385 | 2 640 |
| Equity | 226 | 269 | 450 | 634 | 272 | 511 | 728 | 1 031 | 622 | 626 | 492 | 310 | 542 | 1 466 |
| Long-term debt | 0 | 4 | 10 | 24 | 10 | 9 | 7 | 6 | 7 | 4 | 0 | 0 | 2 | 0 |
| Short-term debt | 856 | 1 132 | 1 746 | 1 430 | 798 | 530 | 592 | 678 | 484 | 491 | 215 | 435 | 841 | 1 174 |
| Total debt | 856 | 1 136 | 1 756 | 1 454 | 808 | 539 | 599 | 684 | 492 | 495 | 215 | 435 | 842 | 1 174 |
EBITDA margin
40.0%
This company
15.8%
Market median
+153% vs market
20122025
Equity ratio
55.5%
This company
38.2%
Market median
+45% vs market
20122025
Return on equity
131.2%
This company
18.4%
Market median
+613% vs market
20122025
Net profit margin
31.1%
This company
8.1%
Market median
+284% vs market
20122025
Asset turnover
2.34×
This company
1.12×
Market median
+109% vs market
20122025
Debt / equity
0.80×
This company
0.62×
Market median
+29% vs market
20122025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JH Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
KM Deputy Member | Deputy Member | 2012 | — | — |
SM Chief Executive Officer | Chief Executive Officer | 2012 | — | — |
AA Deputy Member | Deputy Member | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2012 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HEMO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jon Hægland | Chief Executive Officer | 0 companies |
| Katrine Mæland | Deputy Member | 0 companies |
| Steinar Moberg | Chief Executive Officer | 0 companies |
| Aina Alice Kyte Moberg | Deputy Member | 0 companies |
| Otto Hægland | Chairman | 0 companies |